Biosceptre minimises dilution of the existing shareholder value by seeking new funding in line with the expected increase in the enterprise value of Biosceptre.  In addition Biosceptre will continue to seek and utilise grant funding.  It is planned that capital will be raised at annual intervals.  If you are interested in investing in Biosceptre, please email for information.

This does not constitute an offer to sell, or the solicitation of an offer to buy, any securities to any person to whom, or in any place in which, it would be unlawful to make such an offer.